Literature DB >> 12393881

Transforming growth factor beta (TGFbeta ) signaling via differential activation of activin receptor-like kinases 2 and 5 during cardiac development. Role in regulating parasympathetic responsiveness.

Simone M Ward1, Jay S Desgrosellier, Xiaoli Zhuang, Joey V Barnett, Jonas B Galper.   

Abstract

Little is known regarding factors that induce parasympathetic responsiveness during cardiac development. We demonstrated previously that in atrial cells cultured from chicks 14 days in ovo, transforming growth factor beta (TGFbeta) decreased parasympathetic inhibition of beat rate by the muscarinic agonist, carbamylcholine, by 5-fold and decreased expression of Galpha(i2). Here in atrial cells 5 days in ovo, TGFbeta increased carbamylcholine inhibition of beat rate 2.5-fold and increased expression of Galpha(i2). TGFbeta also stimulated Galpha(i2) mRNA expression and promoter activity at day 5 while inhibiting them at day 14 in ovo. Over the same time course expression of type I TGFbeta receptors, chick activin receptor-like kinase 2 and 5 increased with a 2.3-fold higher increase in activin receptor-like kinase 2. Constitutively active activin receptor-like kinase 2 inhibited Galpha(i2) promoter activity, whereas constitutively active activin receptor-like kinase 5 stimulated Galpha(i2) promoter activity independent of embryonic age. In 5-day atrial cells, TGFbeta stimulated the p3TP-lux reporter, which is downstream of activin receptor-like kinase 5 and had no effect on the activity of the pVent reporter, which is downstream of activin receptor-like kinase 2. In 14-day cells, TGFbeta stimulated both pVent and p3TP-lux. Thus TGFbeta exerts opposing effects on parasympathetic response and Galpha(i2) expression by activating different type I TGFbeta receptors at distinct stages during cardiac development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393881     DOI: 10.1074/jbc.M209668200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.

Authors:  Melania E Mercado-Pimentel; Antony D Hubbard; Raymond B Runyan
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

2.  Endocardial cell epithelial-mesenchymal transformation requires Type III TGFβ receptor interaction with GIPC.

Authors:  Todd A Townsend; Jamille Y Robinson; Tam How; Daniel M DeLaughter; Gerard C Blobe; Joey V Barnett
Journal:  Cell Signal       Date:  2011-09-14       Impact factor: 4.315

3.  Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium.

Authors:  Harold E Olivey; Nathan A Mundell; Anita F Austin; Joey V Barnett
Journal:  Dev Dyn       Date:  2006-01       Impact factor: 3.780

4.  Functions of the type 1 BMP receptor Acvr1 (Alk2) in lens development: cell proliferation, terminal differentiation, and survival.

Authors:  Ramya Rajagopal; Lisa K Dattilo; Vesa Kaartinen; Chu-Xia Deng; Lieve Umans; An Zwijsen; Anita B Roberts; Erwin P Bottinger; David C Beebe
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

5.  Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.

Authors:  C S Craft; D Romero; C P H Vary; R C Bergan
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

6.  Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP.

Authors:  Ho-Jin Park; Serban P Georgescu; Chuang Du; Christopher Madias; Mark J Aronovitz; C Michael Welzig; Bo Wang; Ulrike Begley; Yali Zhang; Robert O Blaustein; Richard D Patten; Richard H Karas; Herbert H Van Tol; Timothy F Osborne; Hitoshi Shimano; Ronglih Liao; Mark S Link; Jonas B Galper
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.